annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce that MST Access will host an âAsk the Expertâ conference call with Professor Jason S. Slakter, M.D. on Tuesday 13th December 6:30pm â 7:30pm EST USA (Wednesday 14th December 10:30am â 11:30am AEDT).
Prof Slakter is a board certifi...
>>> Read more: Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce that MST Access will host an âAsk the Expertâ conference call with Professor Jason S. Slakter, M.D. on Tuesday 13th December 6:30pm â 7:30pm EST USA (Wednesday 14th December 10:30am â 11:30am AEDT).
Prof Slakter is a board certifi...
>>> Read more: Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
